Memory T Lymphocytes in Cancer Immunology (R01)

The summary for the Memory T Lymphocytes in Cancer Immunology (R01) Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the government agency that is offering this grant.
Federal Grant Title: Memory T Lymphocytes in Cancer Immunology (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-255
Type of Funding: Grant
CFDA Numbers: 93.396
CFDA Descriptions: Cancer Biology Research
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announcement for details.
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announcement for details.
Posted Date: Dec 20, 2006
Creation Date: Dec 05, 2008
Archive Date: Jun 01, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Grant Description
-Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits applications from organizations that propose to conduct basic research studies that are relevant to antitumor immunity and that are focused on memory T lymphocytes and/or the cells and molecules that interact with memory T lymphocytes. Such research may include investigations of T memory cell differentiation, maintenance, and reactivation. Investigations may entail both human and animal studies, and both in vitro and in vivo analyses. Innovative uses of existing technologies and reagents, as well as the development of new technologies and reagents, are encouraged. We anticipate that the results of such research will ultimately improve the prospects for successful cancer immunotherapies and cancer vaccine development. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-06-349, that solicits applications under the Exploratory/Developmental Grant (R21) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/pa-07-255.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Revision Applications for Research on Metabolic Reprogramming to Improve Immunotherapy (P0...
Revision Applications for Research on Metabolic Reprogramming to Improve Immunotherapy (U0...
Revision Applications for Research on Metabolic Reprogramming to Improve Immunotherapy (R0...
Revisions for Early-Stage Development of Informatics Technology (P01)
Advanced Development of Informatics Technology (U24)
Mouse Models of Human Cancers Consortium
Integrative Cancer Biology Programs
Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School...
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC...
Mucosal Environment and HIV Prevention (MEHP II) (R01)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com